Below are our currently enrolling studies for patients with gout.
/assets/docs/421576.png)
Sponsor: LG Chem, LTD
Protocol Number: LG-GDCL010
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.
Detailed Information: Here
To learn more or see if you qualify: Click Here
/assets/docs/421578.png)
Sponsor: Olatec Therapeutics LLC
Protocol Number: OLT1177-08
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Detailed Information: Here
To learn more or see if you qualify: Click Here